Oncology research has been slower to adopt digital clinical measures than other therapeutics specialties in healthcare and drug development.
Thought leaders are working to reverse this trend and rapidly integrate digital clinical measures in oncology patient care and clinical research.
Hosted by Xtalks, Jeremy Wyatt, Chief Executive Officer, ActiGraph, and Kate Lyden, PhD., Chief Science Officer, VivoSense, join industry experts to discuss:
- The reasons behind and the missed opportunities from the slow adoption of these measures.
- Examples of successful deployment of wearable and remote monitoring technologies to improve clinical outcomes in cancer patients.
Fill out the form to watch the on-demand webinar today!